- This topic has 0 replies, 1 voice, and was last updated 3 weeks, 6 days ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Immunotherapy for TNBC uses the body’s immune system to recognize and attack triple-negative breast cancer cells. By stimulating immune responses or targeting specific checkpoints, **immunotherapy for TNBC** can slow tumor growth, enhance treatment effectiveness, and provide new options for patients with limited responses to conventional therapies.
Viewing 1 post (of 1 total)
- You must be logged in to reply to this topic.